抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Osocimab
All
TD-HY171016_1.jpg
TD-HY171016_2.jpg
- Catalog： TD-HY171016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： BAY1213790,CAS:2056878-75-0,FXI,FXIa
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Osocimab
| Catalog No. | TD-HY171016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Human |
| Isotype | IgG1-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | Plasma thromboplastin antecedent, PTA, Coagulation factor XI, F11, FXI |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P03951 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | BAY1213790,CAS:2056878-75-0,FXI,FXIa |
| Background | Osocimab (BAY 1213790), an anti-FXIa antibody (Ki=2.4 nM; EC50=0.2 nM). FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SEC-HPLC detection for Research Grade Osocimab. |
|
|
SDS-PAGE for Research Grade Osocimab. |